Overview
The Post-Vitrectomy Lenstatin™ Study
Status:
Completed
Completed
Trial end date:
2015-12-01
2015-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To determine the efficacy of Lenstatin™, an over-the-counter nutritional supplement, in inhibiting the progression of nuclear cataract in eyes after pars plana vitrectomy.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Lenstatin LLC
Criteria
Inclusion Criteria:- Adults over the age of 18
- Post pars plana vitrectomy surgery
Exclusion Criteria:
- Pediatric patients under the age of 18
- Pregnant women
- Hypersensitivity to any of the ingredients in Lenstatin